Cancer that spreads to bones can be deadly, and it also tends to be painful. Now, a drug seems to address both problems by disrupting the interplay between nerves and tumours, suggesting the approach ...
For patients with breast cancer, administration of pegfilgrastim 72 hours postchemotherapy reduces pegfilgrastim-induced bone pain (PIBP) compared with administration at 24 and 48 hours, according to ...
13don MSN
Promising new therapy developed for most common form of bone cancer in children and young adults
Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has ...
Teva’s biosimilar, PONLIMSI™, is now FDA-approved across all indications of the reference product, Prolia ® (denosumab), to treat a variety of ...
Am J Health Syst Pharm. 2006;63(5):419-430. During resorption, growth factors and proteins released from osteoblast precursors and bone stimulate the differentiation, chemotaxis, and proliferation of ...
Researchers from UC Davis and Lawrence Livermore National Laboratory developed and studied a new material — engineered bone marrow, or eBM. Engineered bone marrow offers a better way to study ...
A discussion with the patient about the importance of bone health when treated with androgen-deprivation therapy (ADT) should ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results